Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
5.06M
Number of holders
11
Total 13F shares, excl. options
79.4K
Shares change
+58.8K
Total reported value, excl. options
$152K
Value change
+$100K
Number of buys
4
Number of sells
-3
Price
$1.91

Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q1 2025

13 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q1 2025.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 79.4K shares of 5.06M outstanding shares and own 1.57% of the company stock.
Largest 10 shareholders include Altium Capital Management LLC (50.5K shares), UBS Group AG (19.9K shares), SBI Securities Co., Ltd. (5.22K shares), MORGAN STANLEY (3.83K shares), NATIONAL BANK OF CANADA /FI/ (10 shares), BANK OF AMERICA CORP /DE/ (5 shares), OSAIC HOLDINGS, INC. (2 shares), Farther Finance Advisors, LLC (1 shares), TD Waterhouse Canada Inc. (1 shares), and Rise Advisors, LLC (1 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.